by Camille Bello | Jun 2, 2026 | News & Events
PRI, the Pharmabiotic Research Institute, and IPA Europe, representing the European probiotic industry, provide supporting information and legal references on the status of isolated microbial strains to avoid unintended impacts on research, innovation, and European...
by Camille Bello | Jan 21, 2026 | Microbiome Product Developer, Pharma (Human)
Jaroslaw Bilinski, MD PhD, Assoc. Prof. CEO, Founder Human Biome (HBI) is a third-generation microbiome company developing the world’s first biosynthetic, donor-independent, bio-mimetic microbiome biotherapeutics—internally referred to as New-Generation...
by Camille Bello | Jan 21, 2026 | Microbiome Product Developer, Pharma (Veterinary)
Barbara Simionati Co-Founder EuBiome is an innovative startup and spin-off of the University of Padua. We are a team of professionals, passionate about microbiome and innovation. We believe in the enormous potential of the microbiome, and we want to contribute to...
by Camille Bello | Jan 21, 2026 | Diagnostics
Dr. Joseph El Khoury-Hanna Chirurgien-dentiste / Founder Biorme is a research-driven company developing non-diagnostic analytical frameworks to characterize functional states of the oral microbiome. Their work focuses on building interpretable, probabilistic models...
by Camille Bello | Nov 25, 2025 | Microbiome Pre-Clinical Research (CRO), Microbiome Clinical Research (CRO)
Silvia Trasciatti Chief Scientific Officer Galileo Research is specialized in non-clinical Discovery and Development services for the LifeSciences sector. Their expertise empowers companies in the pharmaceutical, medical device,novel foods, and dietary supplements...
